ABSTRACT
Foi realizado um estudo retrospectivo do líquido cérebro-espinhal de cães (LCE), atendidos pelo Serviço de Neurologia do Hospital Veterinário da Instituição, de 2004 a 2015, com o objetivo de analisar os resultados de cães com sinais neurológicos, comparar as alterações encontradas em dois locais de colheita no mesmo paciente e verificar se esse exame auxiliou o clínico em reforçar a suspeita clínica das principais doenças do sistema nervoso central. A pleocitose linfocítica esteve presente em 78,3% (29/37) das amostras de cães com cinomose e em 23,2% (10/43) de cães com DDIV. Houve dissociação albuminocitológica (DAC) em 73% (19/26) das amostras de cães com tumores IC e em 64,3% (9/14) de cães com tumores envolvendo a ME. Em cães com DDIV, houve significância estatística (p<0,05) entre o grau de disfunção neurológica e o total de células nucleadas (TCN) e total de proteínas (TP). Em 29 cães, houve a colheita do LCE da cisterna magna e da cisterna lombar e em 12 (41,4%) os resultados foram diferentes entre as duas amostras colhidas do mesmo cão, onde dois (6,9%) apresentaram alteração na amostra colhida cranial à lesão. Pode-se concluir que a pleocitose linfocítica foi a principal alteração encontrada no LCE de cães com cinomose e DDIV e DAC nas neoplasias, IC e ME, cães acometidos pela DDIV apresentaram sinais neurológicos mais severos conforme o TCN e o TP aumentaram e o LCE sofreu alteração, mesmo colhido cranial ao local da lesão e auxiliou o clínico em reforçar a suspeita clínica, mas não confirmou, as principais doenças neurológicas em cães.(AU)
A retrospective study including the analysis of the cerebrospinal fluid (CSF) of dogs neurologically affected was conducted by the Neurology Service of the Veterinary Hospital at the Institution, between 2004 and 2015. The aim of this study was to analyze the results of the CSF of dogs with neurological signs, and compare the changes in the CSF in two sampling sites in the same patient and see if this test helped the clinician to strengthen clinical suspicion of the major diseases of the central nervous system. Lymphocytic pleocytosis was present in 78.3% (29/37) of samples from dogs with distemper and in 23.2% (10/43) of samples from dogs with IVDD. The albumin cytologic dissociation (ACD) was found in 73% (19/26) of samples from dogs with IC tumors and in 64.3% (9/14) from dogs with tumors involving the SC. For dogs with IVDD, there was statistical significance (p<0.05) between the degree of neurological dysfunction and the total nucleated cells (TNC) and total protein (TP). In 29 dogs, CSF was collected from the cistern magna and the lumbar and in 12 (41.4%) the results were different between the samples of the same dog, where two cases (6,9%) showed alterations in the sample collected cranial to the injury. It can be concluded that the lymphocytic pleocytosis was the main alteration found in the CSF of dogs with distemper and IVDD and ACD in tumors. Dogs affected by IVDD had more severe neurological signs as TNC and TP increased and the CSF was altered even collected cranial to the lesion site and helped the clinician to strengthen the clinical suspicion, but not confirm, the major neurological diseases in dogs.(AU)
Subject(s)
Animals , Dogs , Dogs/abnormalities , Nervous System Diseases/veterinary , Cerebrospinal Fluid , LeukocytosisABSTRACT
Quercetin is reported to exert a plethora of health benefits through many different mechanisms of action. This versatility and presence in the human diet has attracted the attention of the scientific community, resulting in a huge output of in vitro and in vivo (preclinical) studies. Therefore, we hypothesized that quercetin can protect Na+,K+-ATPase activity in the central nervous system, reestablish the peripheral cholinesterases activities, and reduce oxidative stress during demyelination events in rats. In line with this expectation, our study aims to find out how quercetin acts on the Na+,K+-ATPase activity in the central nervous system, peripheral cholinesterases, and stress oxidative markers in an experimental model of demyelinating disease. Wistar rats were divided into 4 groups: vehicle, quercetin, ethidium bromide (EB), and EB plus quercetin groups. The animals were treated once a day with vehicle (ethanol 20%) or quercetin 50 mg/kg for 7 (demyelination phase, by gavage) or 21 days (remyelination phase) after EB (0.1%, 10 µL) injection (intrapontine).The encephalon was removed, and the pons, hypothalamus, cerebral cortex, hippocampus, striatum, and cerebellum were dissected to verify the Na+,K+-ATPase activity. Our results showed that quercetin protected against reduction in Na+,K+-ATPase in the pons and cerebellum in the demyelination phase, and it increased the activity of this enzyme in the remyelination phase. During the demyelination, quercetin promoted the increase in acetylcholinesterase activity in whole blood and lymphocytes induced by EB, and it reduced the increase in acetylcholinesterase activity in lymphocytes in the remyelination phase. On day 7, EB increased the superoxide dismutase and decreased catalase activities, as well as increased the thiobarbituric acid-reactive substance levels. Taken together, these results indicated that quercetin regulates the Na+,K+-ATPase activity, affects the alterations of redox state, and participates in the reestablishment of peripheral cholinergic activity during demyelinating and remyelination events.
Subject(s)
Acetylcholinesterase/metabolism , Antioxidants/pharmacology , Demyelinating Diseases/metabolism , Oxidative Stress/drug effects , Quercetin/pharmacology , Remyelination/physiology , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Antioxidants/metabolism , Brain/drug effects , Brain/metabolism , Catalase/metabolism , Disease Models, Animal , Lymphocytes/metabolism , Male , Oxidation-Reduction , Plant Extracts/pharmacology , Rats, Wistar , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive SubstancesABSTRACT
AIM: The purpose of this study was to investigate whether the flavonoid quercetin can prevent alterations in the behavioral tests and of cholinergic neurotransmission in rats submitted to the ethidium bromide (EB) experimental demyelination model during events of demyelination and remyelination. MAIN METHODS: Wistar rats were randomly distributed into four groups (20 animals per group): Control (pontine saline injection and treatment with ethanol), Querc (pontine saline injection and treatment with quercetin), EB (pontine 0.1% EB injection and treatment with ethanol), and EB+Querc (pontine 0.1% EB injection and treatment with quercetin). The groups Querc and Querc+EB were treated once daily with quercetin (50mg/kg) diluted in 25% ethanol solution (1ml/kg) and the animals of the control and EB groups were treated once daily with 25% ethanol solution (1ml/kg). Two stages were observed: phase of demyelination (peak on day 7) and phase of remyelination (peak on day 21 post-injection). Behavioral tests (beam walking, foot fault and inclined plane test), acetylcholinesterase (AChE) activity and lipid peroxidation in pons, cerebellum, hippocampus, hypothalamus, striatum and cerebral cortex were measured. KEY FINDINGS: The quercetin promoted earlier locomotor recovery, suggesting that there was demyelination prevention or further remyelination velocity as well as it was able to prevent the inhibition of AChE activity and the increase of lipidic peroxidation, suggesting that this compound can protect cholinergic neurotransmission. SIGNIFICANCE: These results may contribute to a better understanding of the neuroprotective role of quercetin and the importance of an antioxidant diet in humans to provide benefits in neurodegenerative diseases such as MS.
Subject(s)
Cholinergic Neurons/drug effects , Demyelinating Diseases/prevention & control , Ethidium/toxicity , Motor Activity/drug effects , Neuroprotective Agents/therapeutic use , Quercetin/therapeutic use , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Cholinergic Neurons/physiology , Demyelinating Diseases/chemically induced , Demyelinating Diseases/physiopathology , Male , Motor Activity/physiology , Neuroprotective Agents/pharmacology , Quercetin/pharmacology , Random Allocation , Rats , Rats, Wistar , Synaptic Transmission/drug effects , Synaptic Transmission/physiologyABSTRACT
O objetivo deste estudo foi identificar cães com epilepsia e obter informações a respeito da raça, do sexo, da idade, da classificação da epilepsia e da crise convulsiva, dos estágios e do período de ocorrência das crises convulsivas. Em 66,7% (44/66) dos cães a epilepsia foi primária, em 21,2% (14/66) sintomática e em 12,1% (8/66) provavelmente sintomática. Os cães sem raça definida (27%) foram os mais acometidos e a faixa etária predominou entre um e cinco anos de idade. A crise convulsiva generalizada tônico-clônica (66,7%) foi a mais observada, a procura pelo dono (72,7%) no período pré-ictal e o andar compulsivo (60,5%) no período pós-ictal foram os sinais mais encontrados e a ocorrência das crises convulsivas foi maior no período noturno (79,2%).
The objective of this study was to identify dogs with epilepsy and to obtain information about breed, sex, age, classification of the epilepsy and the seizures, as well as the stage and time of occurrence of the seizures. Epilepsy was primary in 66.7% (44/66) of dogs, symptomatic in 21.2% (14/66), and probably symptomatic in 12.1% (8/66). Crossbred dogs (27%) were the most affected and the predominant age group ranged from one to five years; the generalized tonic-clonic seizures (66.7%) was the most frequent presentation. The search for the owner (72.7%) during the preictal period and the compulsive walking (60.5%) in post-ictal period were the more frequent signs observed in the affected dogs, and the occurrence of seizures was higher at night (79.2%).
Subject(s)
Animals , Dogs , Dogs/abnormalities , Epilepsy, Tonic-Clonic/veterinary , Epilepsy/veterinary , Epilepsies, Myoclonic/veterinary , Age Distribution , Cerebrospinal Fluid , Signs and SymptomsABSTRACT
O objetivo deste estudo retrospectivo foi avaliar a recuperação funcional de cães paraplégicos sem percepção à dor profunda (PDP) com doença do disco intervertebral (DDIV) toracolombar submetidos à hemilaminectomia dorsolateral. Foram incluídos somente cães com DDIV entre os segmentos da medula espinhal T3 e L3, que estavam paraplégicos sem PDP submetidos à cirurgia descompressiva. Foi observada recuperação funcional satisfatória em 73,3% dos cães (n=11), sendo um, aos cinco dias, sete entre 15 e 30 dias e três acima de 30 dias do procedimento cirúrgico. A duração da perda da PDP antes da cirurgia em cinco cães recuperados foi entre 12 e 48 horas e, em seis cães, acima de 48 horas. Cães paraplégicos sem PDP em decorrência da DDIV toracolombar podem apresentar recuperação funcional satisfatória quando submetidos ao tratamento cirúrgico mesmo sem percepção a dor profunda com tempo superior a 48 horas. Futuras pesquisas serão necessárias para avaliar a eficiência do tratamento cirúrgico, principalmente para aqueles que perderam a PDP acima de 48 horas.
This retrospective study was to evaluate the functional recovery of paraplegic dogs without deep pain perception (DPP) with intervertebral disc disease (IVDD) submitted to dorsolateral hemilaminectomy. Only dogs with IVDD between spinal cord segments T3 and L3, which were paraplegic without DPP and were submitted to decompressive surgery were included in the study. Satisfactory functional recovery was observed in 73.3% of the dogs (n=11). Recovery time after surgery was one day (one dog), between 15 and 30 days (seven dogs) and over 30 days 30 days 3 dogs). The duration of the lack of DPP before surgery was 12-48 hours, in five recovered dogs and over 48 hours in six recovered dogs It can be concluded that paraplegic dogs with thoracolumbar IVD and lack of DPP may present satisfactory functional recovery when submitted to surgical treatment even when the absence of deep pain perception has settled for more than 48 hours. Further research is needed to better evaluate the effectiveness of surgical treatment, mainly for dogs with lack of DPP over 48 hours.
Subject(s)
Animals , Dogs , Dogs/injuries , Decompression, Surgical/veterinary , Intervertebral Disc/pathology , Pain Perception , Gait Disorders, Neurologic/veterinaryABSTRACT
O objetivo deste estudo retrospectivo foi identi [1]icar cães com neoplasmas envolvendo o sistema nervoso central (SNC), atendidos entre janeiro de 2003 a junho de 2011, no HVU-UFSM, e obter informações a respeito da raça, do sexo, da idade, dos sinais neurológicos, da localização, da evolução clínica, do tipo e da origem do tumor e dos achados de exames complementares. Os 26 neoplasmas envolvendo o SNC incluídos nesse estudo ocorreram principalmente em Boxers (35%), com predomínio de idade de cinco anos ou mais (92,3%). A evolução dos sinais clínicos nos neoplasmas encefálicos variou entre sete e 115 dias e nos medulares entre sete a 420 dias. Os sinais neurológicos principais em cães com neoplasmas encefálicos e medulares foram alteração do nível de consciência (58%), caracterizada principalmente por sonolência, e hiperestesia espinhal (57%), respectivamente. As regiões tálamo-cortical e T3-L3 foram as mais acometidas (58% e 43%, respectivamente). Dos 12 neoplasmas que afetaram o encéfalo, 10 eram primários (83,3%). Dos 14 neoplasmas que afetaram a medula espinhal, apenas quatro eram primários (28,6%). Dos neoplasmas encefálicos e medulares primários, o mais comum foi o meningioma, perfazendo 40% e 75% dos casos, respectivamente.
This retrospective study was aimed to identify dogs with neoplasms affecting the central nervous system (CNS) and compile information on the affected breeds, sex, age group, anatomical site of the tumor, type of clinical signs and clinical course, and laboratory results. The study included the cases submitted to the Veterinary Teaching Hospital (HVU) of the Federal University of Santa Maria (UFSM), Brazil, from January 2003 to June 2011. The 26 neoplasms affecting the CNS included in this study occurred mainly in Boxers (35%) and the predominantly affected age-group was 5-year-old or older (92.3%). The course of clinical signs in dogs with brain neoplasms was 7-115 days and that of spinal cord tumors was 7-420 days. The most frequently observed neurological signs in dogs with brain and spinal cord neoplasms were respectively changes in the conscience levels (58%), which were characterized by somnolence, and spinal hyperesthesia (57%). The cortico-thalamic region and the T3-L3 spinal cord segment were the most frequently anatomical sites involved (58% and 43%, respectively). Ten out 12 neoplasms affecting the brain were primary (83.3%) whereas only four of those 14 neoplasms affecting the spinal cord were primary (28.6%). Meningioma was the most frequent m primary neoplasms affecting the brain and spinal cord of dogs, consisting respectively of 40% e 75% of the cases.
Subject(s)
Animals , Dogs , Dogs , Diagnostic Imaging/veterinary , Meningioma/veterinary , Myelography/veterinary , Central Nervous System Neoplasms/veterinary , Signs and Symptoms , Unconsciousness/veterinary , Radiography/veterinary , Ultrasonography/veterinaryABSTRACT
O objetivo deste estudo foi identificar cães com doença do disco intervertebral (DDIV) cervical atendidos no Hospital Veterinário Universitário (HVU) da Universidade Federal de Santa Maria (UFSM) entre janeiro de 2003 e outubro de 2008 e obter informações a respeito de raça, sexo, idade, sinais neurológicos, resposta ao tratamento cirúrgico, complicações, tempo de recuperação funcional após a cirurgia e ocorrência de recidiva. Hiperestesia cervical foi observada em todos os cães (n=28). Quanto ao grau de disfunção neurológica foram verificados: grau I (8/28[28,5 por cento]), grau II (3/28 [10,7 por cento]), grau III (5/28[17,8 por cento]) e grau V (12/2 [42,8 por cento]). A duração dos sinais neurológicos antes da cirurgia em sete cães (25 por cento) permaneceu por até 15 dias, em 14 cães (50 por cento) entre 15 e 30 dias e nos outros sete cães (25 por cento) por mais de 30 dias. A recuperação satisfatória e sem recidiva foi observada em todos os cães submetidos ao tratamento cirúrgico e que sobreviveram (n=21). Pode-se concluir que a DDIV cervical em nossa rotina acomete principalmente cães adultos, machos, de raças condrodistróficas e não condrodistróficas, incluindo as de grande porte; a hiperestesia cervical é a principal manifestação clínica; a técnica de fenda ventral promove recuperação funcional satisfatória e sem recidiva; as principais complicações trans-operatórias são a hemorragia do plexo venoso, a bradicardia e a hipotensão; e a duração dos sinais clínicos não interfere no tempo de recuperação pós-operatória dos cães.
The aim of this study was to evaluate the medical records of dogs with cervical intervertebral disk disease (IDD), submitted to surgical treatment at the Hospital Veterinário Universitário of Universidade Federal de Santa Maria (HVU-UFSM), between January 2003 and October 2008. The animal data included breed, sex, age, neurological signs and their durations, response to surgical treatment, complications, time for functional recovery after surgery, and recurrence. All dogs showed cervical hyperaesthesia confirmed by the neck movement test. Regarding the degree of neurological dysfunction, the following were verified: degree I (eight dogs, 28.5 percent), degree II (three dogs, 10.7 percent), degree III (five dogs, 17.8 percent), and degree V (twelve dogs, 42.8 percent). In relation to the duration of neurological signs prior to surgery, seven dogs (25 percent) showed neurological deficits for up to 15 days, fourteen dogs (50 percent) for 15 to 30 days and the other seven dogs (25 percent) showed signs of neurological deficiencies for more than 30 days. All dogs (n=21) showed satisfactory recovery and no recurrence. It can be concluded that most affected dogs are middle aged, males and condrodystrophic and noncondrodystrophic breeds including large-breed dogs and the main neurological sign is cervical hyperaesthesia. The surgical treatment promotes satisfactory functional recovery and no recurrence, the main complications intraoperative are venous plexus hemorrhage, bradycardia and hypotension and the duration of clinical signs prior to surgery do not interfere with the recovery time of the dogs.
Subject(s)
Animals , Male , Female , Dogs , Dogs/surgery , Intervertebral Disc/surgery , Intervertebral Disc/physiopathology , Gait Disorders, Neurologic/surgery , Gait Disorders, Neurologic/rehabilitation , Gait Disorders, Neurologic/veterinary , Anesthesia, General/methods , Anesthesia, General/veterinary , Myelography/methods , Myelography/veterinary , Radiography/methods , Radiography/veterinaryABSTRACT
O objetivo deste experimento foi isolar a musculatura epaxial da medula espinhal de cães submetidos à laminectomia dorsal modificada (LDM) e averiguar se os músculos influenciaram na formação da fibrose epidural, na compressão medular e no aparecimento dos sinais neurológicos. Para isso, dez cães hígidos foram submetidos à LDM entre as vértebras T13 e L1 e distribuídos aleatoriamente em dois grupos denominados controle (I) onde a medula espinhal permaneceu exposta sem a presença de implante, e tratado (II)onde foi colocado um im-plante a base de alumínio entre a musculatura epaxial adjacente e a medula espinhal exposta pela LDM. As avaliações constaram de exames neurológicos diários até 180 dias de pós-operatório (PO); mielografia, decorridos 15, 30 e 60 dias de PO; e avaliação macroscópica mediante a reintervenção cirúrgica. Não houve diferença durante as avaliações neurológicas. Aos 15 dias de PO, foi verificado na mielografia, que o grau de compressão da linha de contraste foi maior no grupo tratado (P<0,05) quando comparado ao grupo controle, não havendo diferença dos demais tempos estudados. Na avaliação macroscópica, pode-se observar que no Grupo II, a musculatura epaxial adjacente à medula espinhal não estava em contato com a fibrose epidural, diferentemente do grupo controle. O implante pôde ser removido facilmente e apresentava discreto grau de deformidade crânio-dorsal. Pode-se concluir que a musculatura epaxial adjacente é isolada da medula espinhal pelo implante à base de alumínio em cães submetidos à LDM, e esta não influencia na formação da fibrose epidural, compressão medular e no aparecimento dos sinais neurológicos.
The purpose of this study was to isolate the adjacent epaxial musculature from exposed spinal cord by modified dorsal laminectomy in dogs with aluminum implant and to verify whether the muscles contribute to form epidural fibrosis, spinal cord compression, and development of neurological signs. Ten dogs were submitted to modified dorsal laminectomy between T13 and L1 and then distributed along two groups. Dogs in the group 1 remained with the spinal cord exposed without the implant; dogs in the group 2 had an aluminum implant inserted between the epaxial muscles and the exposed spinal cord. Neurological examination was daily performed until 180 days post surgery. Additionally, myelography at 15, 30, and 60 days post surgery and macroscopic evaluation of the implant at six months post surgery were done. There was no difference between groups in the neurological examination. A statistical difference in the degree of spinal compression was observed at day 15 post surgery in the group 2. In this group, the epaxial musculature adjacent to the spinal cord was not in contact with the epidural fibrosis, differently to what was observed in the control group. The implant was removed easily with some degree of deformity. The results showed that the adjacent musculature of the spinal cord submitted to a modified dorsal laminectomy in dogs can be isolated by aluminum implant, without any contact with epidural fibrosis or influence in the development of neurological signs.
Subject(s)
Animals , Dogs , Spine/surgery , Laminectomy/adverse effects , Neurosurgical Procedures/adverse effects , Epidural Space/injuries , Fibrosis , Myelography/methodsABSTRACT
O objetivo deste trabalho foi realizar um estudo retrospectivo dos casos de subluxação atlantoaxial em cães, por meio de consulta dos registros neurológicos do Hospital Veterinário Universitário (HVU), entre os anos de 2003 e 2008. Foram identificados a raça, o sexo, a idade, a etiologia, os sinais neurológicos, a duração dos sinais clínicos, o tratamento empregado, a resposta ao tratamento, o tempo de recuperação, a recidiva e a relação entre a duração dos sinais clínicos e a recuperação pós-operatória. Foram feitos o diagnóstico de subluxação atlantoaxial em 14 cães, sendo as raças Poodle (35,7 por cento), Pinscher (21,4 por cento) e Yorkshire Terrier (21,4 por cento) as mais acometidas e a maioria (92,8 por cento) com idade inferior a 24 meses. A principal causa da instabilidade foi a agenesia do processo odontoide do áxis (71,4 por cento) e os sinais clínicos variaram desde hiperestesia cervical até tetraparesia não ambulatória. O tratamento predominante foi o cirúrgico, que demonstrou ser eficaz com recuperação satisfatória em 90 por cento dos casos e menor possibilidade de recidiva, quando comparado ao trata,mento clínico. O tempo de recuperação predominante foi de 30-60 dias após a cirurgia, não existindo relação deste com a duração dos sinais clínicos.
A retrospective study on atlantoaxial subluxation in dogs was done by reviewing the cases filed from 2003 to 2008 in the neurological records of the Veterinary Hospital of the Universidade Federal de Santa Maria, at Santa Maria, Rio Grande do Sul, Brazil. The following data were identified: Breed, sex, age, etiology, clinical signs, duration of clinical course, assessment of the therapy employed and its efficacy, response to treatment and relapse. Fourteen dogs were diagnosed as affected by atlantoaxial subluxation and the condition was more frequent in dogs under twenty-four month old years and of toy breeds, such as Poodle (35.7 percent), Pinscher (21.4 percent) and Yorkshire terrier (21.4 percent). The main cause found for the instability was agenesis of the odontoid process. Clinical signs ranged from cranial cervical pain to non-ambulatory tetraparesis. The predominant treatment employed was surgical which demonstrated to be efficacious in 90 percent of the cases with minor risks of relapse when compared with clinical treatment. The predominant time of recovery was 30-60 days after surgery. No correlation was found between the duration of clinical signs before surgery and the time of recovery.